Panagiotis Baliakas is Director of the Haematology
Diagnostic Laboratory at the Uppsala University Hospital. He is an active
member of ERIC, the European Research Initiative in CLL, and is instrumental in
a number of studies aimed at optimizing prognosis and prediction in CLL. His
current research interests include immunogenetics in human lymphoid
malignancies, genetic characterization of lymphoid and myeloid malignancies and
genomic elucidation of predisposition syndromes to hematological malignancies.
You can see my upcoming and previous webinars here.
